ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,625Medicare Part D Prescriptions Filled, Including Refills

Rank: 10 out of 663

$860K Total Retail Price of All Prescriptions

Rank: 14 out of 663

387 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
78% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Colorado
Lower avg

Schedule Two
Controlled Substances

30% of this provider’s 387 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

19% of this provider’s 387 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

0% of this provider’s 14,576 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

43 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Colorado
WARFARIN SODIUM 919 837 1 8
FUROSEMIDE 847 811 2 7
LEVOTHYROXINE SODIUM 839 745 3 3
HYDROCODONE-ACETAMINOPHEN 792 731 S3 4 6
LISINOPRIL 492 424 5 2
METOPROLOL TARTRATE 432 393 6 11
TRAMADOL HCL 371 359 7 17
ESCITALOPRAM OXALATE 300 244 8 77
KLOR-CON M20 299 266 9 70
OXYCODONE HCL 296 277 S2 10 41
GABAPENTIN 242 168 11 20
POLYETHYLENE GLYCOL 3350 231 210 12 82
DONEPEZIL HCL 223 210 13 40
POTASSIUM CHLORIDE 220 208 14 23
CITALOPRAM HBR 212 191 15 18
SERTRALINE HCL 210 152 16 35
PREDNISONE 196 191 17 39
CARVEDILOL 193 181 18 47
SIMVASTATIN 190 184 19 1
QUETIAPINE FUMARATE 189 158 20 69
OXYCONTIN 179 154 S2 21 98
LANTUS 172 156 22 48
AMLODIPINE BESYLATE 163 136 23 5
LEVOFLOXACIN 155 120 24 92
METOPROLOL SUCCINATE 152 152 25 25
CARBIDOPA-LEVODOPA 147 127 26 102
FENTANYL 138 132 S2 27 75
NAMENDA 132 118 28 57
DIVALPROEX SODIUM 131 105 29 81
RISPERIDONE 126 82 30 87
METFORMIN HCL 126 95 30 9
OMEPRAZOLE 123 100 32 4
IPRATROPIUM-ALBUTEROL 123 122 32 108
ADVAIR DISKUS 117 116 34 53
MIRTAZAPINE 116 98 35 52
TAMSULOSIN HCL 116 116 35 24
LIDODERM 113 113 37 67
PAROXETINE HCL 112 90 38 68
OXYCODONE-ACETAMINOPHEN 106 84 S2 39 26
ATENOLOL 102 102 40 10
LYRICA 102 102 40 96
MORPHINE SULFATE 101 94 S2 42 211
BACLOFEN 99 45 43 122
OXYBUTYNIN CHLORIDE ER 99 94 43 121
NOVOLOG 98 97 45 143
GLIPIZIDE 95 95 46 29
OLANZAPINE 92 82 47 88
ATORVASTATIN CALCIUM 89 69 48 13
LOSARTAN POTASSIUM 89 88 48 14
ALBUTEROL SULFATE 88 88 50 177
VENLAFAXINE HCL ER 86 86 51 86
CYMBALTA 86 74 51 54
CLOTRIMAZOLE 85 79 53 273
DIGOXIN 83 83 54 50
KLOR-CON 10 82 82 55 160
VANCOMYCIN HCL 78 60 56 174
LATANOPROST 74 74 57 157
OXYBUTYNIN CHLORIDE 74 42 57 99
LEVETIRACETAM 73 50 59 123
MORPHINE SULFATE ER 71 39 S2 60 51
LEXAPRO 71 59 60 197
RANITIDINE HCL 69 46 62 31
LACTULOSE 66 66 63 111
ALLOPURINOL 65 65 64 28
SPIRIVA 65 65 64 62
TRAZODONE HCL 64 61 66 34
SPIRONOLACTONE 62 61 67 58
SEROQUEL 61 53 68 176
CIPROFLOXACIN HCL 57 52 69 74
VENLAFAXINE HCL 56 22 70 166
HYDROMORPHONE HCL 55 0 S2 71 151
LIDOCAINE HCL 54 52 72 315
CEPHALEXIN 54 41 72 119
BETAMETHASONE DIPROPIONATE 54 54 72 315
HUMALOG 53 24 75 194
CEFTRIAXONE 53 52 75 317
CLOPIDOGREL 53 53 75 65
TRAVATAN Z 52 52 78 266
REBIF 52 52 78 266
LANSOPRAZOLE 52 52 78 231
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 29, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.